Bipartisan Push for FDA “Pre-Review” of DTC Drug Ads April 9, 2026 By Charles D. Snow & Dara Katcher Levy —

https://www.thefdalawblog.com/2026/04/bipartisan-push-for-fda-pre-review-of-dtc-drug-ads/?utm_source=rss&utm_medium=rss&utm_campaign=bipartisan-push-for-fda-pre-review-of-dtc-drug-ads As many of our blog readers already know, direct-to-consumer (“DTC”) prescription drug promotion has been a regulatory flashpoint for years, and especially recently with FDA’s DTC crackdown (see our previous posts here, here, and here), but a new bipartisan push suggests the conversation may be shifting from post-publication enforcement to pre-publication review for television ads.